VBC News Public Health Valent BioSciences Contact Us January 12, 2022Valent BioSciences Announces Osage Facility Environmental Initiatives September 23, 2021Valent BioSciences and Kansas State University Sign Collaborative Agreement for Soil Health Research Initiative with Dr. Charles W. Rice July 1, 2021Valent BioSciences Announces U.S. EPA Registration of AccedeTM Plant Growth Regulator for Effective Thinning of Stone Fruit and Apples June 23, 2021Valent BioSciences and Valent U.S.A. Collaborate with Halo on Open Innovation Initiative Seeking New Technologies and Solutions May 5, 2021Valent BioSciences Introduces MetaLarv® XRP for Long-Lasting, Consistent Control in Catch Basin Mosquito Habitats March 5, 2021Valent BioSciences Celebrates 50th Anniversary of DiPel® Biological Insecticide as the Industry’s Most Effective Lepidopteran Control Product December 3, 2020Valent BioSciences Announces New Educational Initiatives Supporting World Soil Day, Healthy Soils, and Sustainable Crop Production November 19, 2020Valent BioSciences Boosts Capabilities with New Biorational Research Unit at Sumitomo Chemical Health & Crop Sciences Research Laboratory October 27, 2020SATT Paris-Saclay and Valent BioSciences Sign Joint Agreement to Develop Breakthrough Sustainable Biopesticide Technologies September 23, 2020Valent BioSciences Announces Creation of New Chief Commercial Officer Position and Other Organizational and Reporting Changes to Drive Growth September 17, 2020Valent BioSciences Moves into New Global Biorational Headquarters August 29, 2018Valent BioSciences, ADAPCO Form Strategic Partnership in Public Health July 25, 2018Valent BioSciences Unveils New Biorational Research Center October 31, 2017Valent BioSciences is Named Winner of Chicago Innovation Award for VectoBac® WDG and WALS™ Application Platform January 19, 2016Valent BioSciences Corporation Reaches Distribution Deal for Actinovate® Brands with The BioAg Alliance March 4, 2015Valent BioSciences Corporation Acquires Mycorrhizal Applications, Inc. February 24, 2015U.S. EPA Approves New VectoPrime™ Biological Larvicide for Single-brood Floodwater Mosquito Larvae Programs June 27, 2014Valent BioSciences Corporation Unveils its State-of-the-Art Biorational Manufacturing Facility in Osage, Iowa December 11, 2013Valent BioSciences Corporation Earns ISO 9001:2008 Re-certification Following a System-Wide Audit October 22, 2013Richards Joins Valent BioSciences Corporation as Plant Manager for new Osage Manufacturing Facility August 19, 2013Ted Melnik Joins Valent BioSciences as Executive Vice President & Chief Operating Officer April 4, 2013Valent BioSciences’ $150M New Manufacturing Facility On Track for Completion in Iowa April 17, 2012MetaLarv™ S-PT Launch Marks Innovative Biorational Mosquito Growth Regulator for Use in Public Health March 16, 2012Groundbreaking Ceremony for Valent BioSciences Marks Growth of Biorational Product Segment in Agriculture February 16, 2012Valent BioSciences Files Patent Applications Claiming Benefits of Abscisic Acid in Animal Feed January 18, 2012Osage, IA, and Valent BioSciences gear up for construction of landmark manufacturing facility October 25, 2011EPA Approves New MetaLarv™ S-PT Mosquito Growth Regulator Featuring Advanced Triple-Release Formulation Technology October 25, 2011EPA Approves New MetaLarv™ S-PT Mosquito Growth Regulator Featuring Advanced Triple-Release Formulation Technology July 20, 2010Valent BioSciences Corporation Achieves ISO 9001:2008 Registration for U.S. Operations April 25, 2010Valent BioSciences Corporation Announces Plan to Construct Fermentation Manufacturing Facility in Osage, Iowa October 9, 2009Novel Microbial Insecticide Product Makes Short List for Two Major Innovation Awards March 26, 2009New VectoMax Biological Larvicide for Mosquito Control
